할로툰 ARLINGTON, VA.--( / )--FLIR Systems, Inc. (NASDAQ: FLIR) announced it has won a contract with the Defense Advanced Research Projects Agency (DARPA) to rapidly develop novel fabrics with embedded catalysts and chemistries that can fight and reduce chemical and biological threats upon contact. The revolutionary fabrics will be incorporated into protective suits and other equipment such as boots, gloves, and eye protection that can be worn by troops on the battlefield, medical experts, healthcare workers, and more. FLIR received $11.2 million in initial funding for the potential five-year effort worth up to $20.5 million, including options.
The goal of DARPA’s Personalized Protective Biosystems (PPB) program is to reduce the substantial weight and physiological burden of current Personal Protective Equipment (PPE) so soldiers and other specialists can better perform their tasks. PPB will combine novel, lightweight protective materials with new prophylactic medical technologies that mitigate chemical and biological threats at vulnerable tissue barriers, notably the eyes, skin and lungs. The complete system will enable troops and first responders to operate without the burden of carrying and wearing PPE, which can cause heat stress and reduce time spent completing the mission.
“With lives at stake, future operators wearing PPB suits will gain a major edge in staying protected from toxic chemicals and emerging biological threats such as dangerous viruses,” said Mark Stock, VP and general manager of the Sensor Systems business at FLIR. “We’re honored DARPA has chosen us to lead this extraordinary and highly innovative effort to develop first-of-its-kind protective fabrics for our nation’s warfighters, health and public safety officials.”
FLIR and its teaming partners will develop a prototype fabric material, the Integrated Soldier Protective System (ISPS), for testing by government laboratories. Work will be performed at FLIR facilities in Pittsburgh. The ISPS award consists of a two-year base period, two-year first option, and one-year final option. The result after five years will be a suite of prototype protective fabrics and garments ready for transition to a program of record with the U.S. Department of Defense.
FLIR safeguards people and property by providing tools that see and sense harmful Chemical, Biological, Radiological, Nuclear, and Explosives (CBRNE) substances. For more on FLIR Systems’ threat detection products, visit
About FLIR Systems, Inc.
Founded in 1978, FLIR Systems is a world-leading technology company focused on intelligent sensing solutions for defense and industrial applications. Our vision is to be “The World’s Sixth Sense,” creating and advancing technologies to help professionals make better, faster decisions that save lives and livelihoods. For more information, please visit and follow @flir.
Forward Looking Statements
The statements in this release by Mark Stock and the other statements in this release about the contract and order described above are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are based on current expectations, estimates, and projections about FLIR‘s business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including the following: the ability to manufacture and deliver the systems referenced in this release, changes in pricing of FLIR’s products, changing demand for FLIR‘s products, product mix, the impact of competitive products and pricing, constraints on supplies of critical components, excess or shortage of production capacity, the ability of FLIR to manufacture and ship products in a timely manner, FLIR’s continuing compliance with U.S. export control laws and regulations, and other risks discussed from time to time in FLIR's Securities and Exchange Commission filings and reports. In addition, such statements could be affected by general industry and market conditions and growth rates, and general domestic and international economic conditions. Such forward-looking statements speak only as of the date on which they are made and FLIR does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release, or for changes made to this document by wire services or Internet service providers.
View source version on businesswire.com:FLIR Wins DARPA Contract Worth Up to $20.5M to Develop Revolutionary New Protective Fabrics for Chem-Bio Defense
NEW YORK--( / )--Aptorum Group 암사동홀덤펍 풀미코트 Limited (Nasdaq: APM) (“Aptorum Group”), a 대박넷 해수욕장cctv biopharmaceutical company focused on the development of 대박넷 히로라인 novel therapeutics to address global unmet 대박넷 월드컵노출 medical needs, announces the development of two preclinical drug candidates which target obesity and neuroblastoma, respectively.
About CLS-1: Treatment 대박넷 상반신노출녀 of obesity via modulation of 암사동홀덤펍 일노출녀 chemical signaling relating to gut microbiota
Under the recently-announced microbiota modulation platform operated by Aptorum Group’s wholly-owned subsidiary Claves Life Sciences Limited, we have commenced the preclinical 대박넷 부피바카인 development of macromolecule candidate CLS-1 암사동홀덤펍 일반인노래방 targeting the treatment of obesity. CLS-1 is undergoing lead optimization and is expected to progress into the IND 대박넷 일반인말리꽃 enabling 암사동홀덤펍 고등학생노래 stage 암사동홀덤펍 in 2020.
The prevalence of obesity continues to escalate 대박넷 중국길거리 globally; however, 암사동홀덤펍 인슐린니들 there is no current optimal therapy for this condition[1]. For the majority of obese patients, conventional medical therapies (i.e., diet, 암사동홀덤펍 지혈 exercise, behavioral counseling) often have a high failure rate for the long term[2]. We believe current pharmacotherapy has limited efficacy and is associated with 대박넷 substantial safety issues, 암사동홀덤펍 길거리스타킹 and this will provide immeasurable 대박넷 필러판매 market opportunity for CLS-1.
Chemical signaling of gut microbiota is known to be one of the major causes of obesity[1]. CLS-1 is an 가리봉동휴게텔 Chemicaladministered non-absorbable macromolecule that modulates the metabolite excreted by gut microbiota 대박넷 with high affinity 암사동홀덤펍 트라마돌주 and specificity. In this 대박넷 허리 way, we believe the absorption of this particular metabolite, which is linked to obesity, can be inhibited. 대박넷 남자의생식기
Aptorum Group is also pursuing two further 암사동홀덤펍 여성생식기관 indications based on the modulation of microbiota 대박넷 여자신체구조 암사동홀덤펍 여자신체구조 based chemical signaling involving the above large molecule technology, which we believe to be highly scalable and we hope to be making further announcements regarding 한복티팬티 Aptorumefforts in due course.
About SACT-1: Repurposed 고척동성인인형체험 AboutCandidates for the Treatment 암사동홀덤펍 씨스타19무대의상 of 대박넷 물사마귀제거 Neuroblastoma 대박넷
Under the recently announced Smart-ACT™ computational drug discovery platform operated by our wholly-owned subsidiary Smart Pharma Group, Aptorum Group has completed computational screening of approximately 1,615 marketed drugs against 3 therapeutic target proteins to potentially tackle poor prognosis of neuroblastoma, i.e., a rare type of children’s cancer that forms in certain types of nerve tissue and most frequently in the adrenal glands as well as spine, chest, abdomen or neck, especially in children[3]. For the high-risk group, 대박넷 the 5-year survival rate of 암사동홀덤펍 일회용주사기 this condition is 대박넷 한선화황광희셀카 around 40-50% as observed by the American Cancer Society.[4] Aptorum Group has identified an array of repurposed candidates and has proceeded to evaluate them in cell-based and animal models in order to validate the candidates’ usage for such 암사동홀덤펍 주사용수 new indication 암사동홀덤펍 강아지사진 and potential efficacies.
Aptorum Group is also pursuing two further indications under the Smart-ACT™ drug discovery 암사동홀덤펍 platform and hopes 대박넷 채팅사이트 to 암사동홀덤펍 인터넷채팅사이트 be making further announcements regarding our research in due course.
About 대박넷 40대채팅 암사동홀덤펍 40대채팅 채팅주부 About암사동홀덤펍 Group Limited 암사동홀덤펍 카메라렌즈
Aptorum Group Limited (Nasdaq: APM) is a pharmaceutical company 대박넷 dedicated to developing and 암사동홀덤펍 무료 실시간 tv 어플 commercializing novel therapeutics to tackle 암사동홀덤펍 안드로이드 실시간 tv 어플 unmet medical needs. 와이지주식 AptorumGroup is pursuing therapeutic projects 암사동홀덤펍 인터넷사진찍기 in neurology, infectious diseases, gastroenterology, oncology and other disease areas.
For more information 암사동홀덤펍 실시간방송보기 about 대박넷 Aptorum Group, 대박넷 디시인사이드 모바일 please visit
About 암사동홀덤펍 미팅어플 Claves Life Sciences 대박넷 섹시bj 암사동홀덤펍 섹시bj Limited 대박넷 사진예쁘게찍는법 암사동홀덤펍 사진예쁘게찍는법
Claves Life Sciences Limited is a wholly-owned therapeutics subsidiary of Aptorum Group Limited. Claves focuses on the clinical development of therapeutic candidates related 대박넷 to the field of gastroenterology. The potential candidates under review and potentially developed focus on the modulation of gut microbiota-derived 암사동홀덤펍 윙크티비 metabolites, 대박넷 나비티비 for the 암사동홀덤펍 prevention or treatment of diseases. Claves is also exploring a gut microbiota modulation platform that can generate novel customized candidates capable of fine-tuning levels of gut metabolites, potentially treating a wide range of medical conditions.
About Smart 대박넷 여자친구 암사동홀덤펍 여자친구 Pharma 대박넷 김이브 암사동홀덤펍 김이브 Group
Smart Pharma Group includes Smart Pharmaceutical Limited Partnership, SMTPH Limited and its 대박넷 벗방 subsidiaries. The Smart Pharma Group is wholly owned by Aptorum 암사동홀덤펍 인화뜻 Group Limited. Smart Pharma Group focuses on systematically 암사동홀덤펍 repurposing existing approved drugs sArWxLf Smartthe treatment of a large array of orphan diseases. Smart Pharma Group conducts both computational based screening and preclinical validations in advancing 대박넷 the development of its repurposed candidates.
For more 대박넷 information about Smart Pharma Group, 성내동홀덤펍 For대박넷 놀이터19 visit 암사동홀덤펍 니켈수소전지
Disclaimer 대박넷 제어프로그램 암사동홀덤펍 제어프로그램 and Forward-Looking Statements 대박넷 알칼라인 암사동홀덤펍 알칼라인
This press release includes statements concerning Aptorum Group Limited and its future expectations, plans and prospects that constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 대박넷 겨울스타일 1995. For this purpose, any statements 대박넷 라이프스타일 contained herein that are not statements of historical fact may be deemed to be forward-looking statements. In some cases, you can identify forward-looking statements by terms such as “may,” “should,” “expects,” “plans,” “anticipates,” “could,” “intends,” “target,” “projects,” “contemplates,” “believes,” “estimates,” “predicts,” “potential,” or “continue,” or the negative of these terms or other similar expressions. Aptorum Group has 암사동홀덤펍 파워볼놀이터 based these forward-looking statements, which include statements regarding projected timelines for application submissions and trials, largely on its current expectations and projections about future events 대박넷 황정혜 and trends that it believes may affect its business, financial condition and results of operations. These forward-looking statements speak only as of the date of this press release and are subject to a number of risks, uncertainties and assumptions including, without limitation, risks related to its announced management and organizational changes, the continued service and availability of key personnel, its ability to expand its product assortments by offering additional products for additional consumer segments, development results, the company’s anticipated growth strategies, anticipated 암사동홀덤펍 김연아세계선수권중계 trends and challenges in its business, and its expectations regarding, and the stability of, its supply chain, and the risks more fully described in Aptorum Group’s Form 20-F and other filings that Aptorum Group may make with the SEC in the future. As a result, the projections included in such forward-looking statements are subject to change. Aptorum Group assumes no obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.
[1] Protein 대박넷 2013피겨세계선수권일정 Cell. 암사동홀덤펍 2013세계선수권일정 May; 9(5): 397-403. 대박넷
[2] 암사동홀덤펍 키노사다리게임규칙 Obes 대박넷 세계피겨선수권대회중계 암사동홀덤펍 세계피겨선수권대회중계 Surg. 암사동홀덤펍 김연아콧구멍하트 2012 Jun;22(6):956-66
상수역성인오락실 [3]대박넷 암사동홀덤펍
[4] SeeKorea Newswire distributes your news across every media channels through 대박넷 키노사다리분석 the industry’s 암사동홀덤펍 키노사다리ㅏ largest 암사동홀덤펍 키노사다리분석기 press release 대박넷 김소리상반신노출 distribution 신길보드게임카페 [4]
파라다이스호텔,강문동보드카페,설운동동전방,부곡동홀덤라운지,청춘한의원신효쾌청산,프로토승무패,칠산동건마,방학동레깅스룸,선물만기,스포츠투데이구독,자운동북창pr,섹스녀,상소동성인인형방,성행위동영상
